Saisei Ventures is a venture capital firm focused on building early-stage companies that will have transformative impacts on human lives. Our aim is to partner with entrepreneurs to develop and implement business strategies that generate strong proof of concept, clinical validation, and market value in the biotechnology sector. With operations in Japan and the US, we take a global approach to building value in our portfolio by linking these two important life science markets and leveraging the respective advantages of each ecosystem.